clinical trials of tacs in psychiatry - diy tdcs

21
Clinical Trials of tACS in Psychiatry Flavio Frohlich University of North Carolina - Chapel Hill Department of Psychiatry Department of Cell Biology and Physiology Department of Biomedical Engineering Department of Neurology Neuroscience Center www.facebook.com/FrohlichLabUNC

Upload: others

Post on 01-Feb-2022

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Clinical Trials of tACS in Psychiatry - DIY tDCS

Clinical Trials of tACSin Psychiatry

Flavio FrohlichUniversity of North Carolina - Chapel Hill

Department of PsychiatryDepartment of Cell Biology and Physiology

Department of Biomedical EngineeringDepartment of Neurology

Neuroscience Center

www.facebook.com/FrohlichLabUNC

Page 2: Clinical Trials of tACS in Psychiatry - DIY tDCS

• UNC owns IP related with FF as the lead inventor.

• UNC has determined the absence of a conflict of interest (COI) for the majority of work presented here and has determined a “COI with administrative considerations” for the clinical trials in the Frohlich Lab.

• FF is the founder, chief scientific officer, and majority owner of Pulvinar Neuro LLC. We provide solutions for transcranial current stimulation research.

• I speak with many companies and have received industry funding from Tal Medical (travel + research).

• I frequently travel and give presentations. I typically receive reimbursement and a stipend.

Conflicts of Interest

Page 3: Clinical Trials of tACS in Psychiatry - DIY tDCS

RATIONAL DESIGN

TargetValidation

TargetIdentification

TargetEngagement

Page 4: Clinical Trials of tACS in Psychiatry - DIY tDCS

Brunelin et al. 2012

Page 5: Clinical Trials of tACS in Psychiatry - DIY tDCS

Frohlich et al. 2016

Page 6: Clinical Trials of tACS in Psychiatry - DIY tDCS
Page 7: Clinical Trials of tACS in Psychiatry - DIY tDCS

• Auditory Hallucinations in SCZ• 10Hz-tACS/tDCS/placebo (double

blind)• 20 min bid / 5 days• 24 pts• Primary: AHRS• Target Engagement: hdEEG

Page 8: Clinical Trials of tACS in Psychiatry - DIY tDCS

• Major depressive disorder• 10Hz-tACS/40Hz-tACS/placebo

(double blind)• 40 min qd / 5 days• 30 pts• Primary: MADRS (4 week follow

up)• Target Engagement: hdEEG

Angel Peterchev

Page 9: Clinical Trials of tACS in Psychiatry - DIY tDCS

Our Experience

SafetyFeasibility

Technology

Page 10: Clinical Trials of tACS in Psychiatry - DIY tDCS

0%10%20%30%40%50%60%70%80%90%

100%

StimulationQuestionnaireResults

Severe

Moderate

Mild

Absent

Page 11: Clinical Trials of tACS in Psychiatry - DIY tDCS

Device Technology

SafetyPlacebo StimulationEffective BlindingQuality Control

Page 12: Clinical Trials of tACS in Psychiatry - DIY tDCS
Page 13: Clinical Trials of tACS in Psychiatry - DIY tDCS

The Future?

…is here?

Page 14: Clinical Trials of tACS in Psychiatry - DIY tDCS

Premenstrual dysphoric disorder (crossover, 10Hz tACS, placebo).

Post-traumatic stress disorder (10Hz tACS, placebo).

Page 15: Clinical Trials of tACS in Psychiatry - DIY tDCS

Lustenberger et al. 2016

Page 16: Clinical Trials of tACS in Psychiatry - DIY tDCS

Lustenberger et al. 2016

Page 17: Clinical Trials of tACS in Psychiatry - DIY tDCS

Lustenberger et al. 2016

Page 18: Clinical Trials of tACS in Psychiatry - DIY tDCS

Lustenberger et al. 2016

Page 19: Clinical Trials of tACS in Psychiatry - DIY tDCS
Page 20: Clinical Trials of tACS in Psychiatry - DIY tDCS
Page 21: Clinical Trials of tACS in Psychiatry - DIY tDCS

Charles ZhouCaroline LustenbergerSankar AlagapanYuhui LiGuoshi LiEhsan NegahbaniJuliann MellinCourtney LugoMorgan AlexanderPhilipp LustenbergerIain StittSupritha DugyalaToheed KhanQuique TolozaNadia MishalMia DeMarcoMatt MattoniJhana ParikhHemanth AmbalaFlorian SchertenleibCarolyn RappAlexandra VossenFranz HamiltonJessica PageMaadhurya Duvvuri

Alumni Lab MembersMohsin AliKristin SellersKatrina KutchkoStephen SchmidtChunxiu YuCarrington Merritt

CollaboratorsECOG: Dr. Haewon ShinSleep Spindles: Dr. Bradley VaughnModeling ECOG: Dr. Jeremy LefebvreElectric Field Spatial Targeting: Dr. Angel PeterchevSCZ Clinical Trial: Dr. Fred Jarskog, Dr. John GilmoreMood Disorders Clinical Trials: Dr. David Rubinow

FundingNIMH BRAINS R01 MH101547, NIMH R21MH105557, NIMH R21MH105574, Human Frontier Science Program, UNC School of Medicine, Department of Psychiatry, NCTraCS(CTSA #1UL1TR001111), Foundation of Hope, UNC SOM TTSA, NARSAD, Tal Medical, Patient Donations.